Literature DB >> 26632360

CRISPR-Cas Gene Editing to Cure Serious Diseases: Treat the Patient, Not the Germ Line.

Ante S Lundberg1, Rodger Novak1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26632360     DOI： 10.1080/15265161.2015.1103817

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  3 in total

1.  Students' attitudes towards somatic genome editing versus genome editing of the germline using an example of familial leukemia.

Authors:  Beate Vajen; Joelle Ronez; Wiebke Rathje; Laura Heinisch; Smilla Ebeling; Ulrich Gebhard; Corinna Hößle; Brigitte Schlegelberger
Journal:  J Community Genet       Date:  2021-05-08

Review 2.  Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate.

Authors:  Silvia Camporesi; Giulia Cavaliere
Journal:  Per Med       Date:  2016-10-28       Impact factor: 2.512

3.  From genomic medicine to precision medicine: highlights of 2015.

Authors:  Charles Auffray; Timothy Caulfield; Julian L Griffin; Muin J Khoury; James R Lupski; Matthias Schwab
Journal:  Genome Med       Date:  2016-01-29       Impact factor: 11.117
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.